DelNS1-2019-nCoV-RBD-OPT1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DelNS1-2019-nCoV-RBD-OPT1, covering 2022-10-28 to 2022-10-28. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2 [Phase 2]